Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Ockham Research (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

East West Bancorp Dinged for Dull Outlook

% of readers think this story is Fact. Add your two cents.


This morning Pasadena, CA based regional bank East West Bancorp (EWBC) reported second quarter earnings that saw the company swing to a profit.  Net income was about $36.3 million or 21 cents per share, three cents better than expected and far more impressive than a loss of $92.1 million a year-ago.  Considered by many a bank with real growth potential, the bank has been active in acquisitions over the last year as they have participated in a couple of deals with distressed banks using FDIC-assistance.

In general, credit trends improved for the bank, and they have slashed their provision for loan losses by 64% to $55.3 million since a year ago.  Furthermore, they expect continued reductions in this safety net in the third quarter.  However, despite topping earnings forecasts the bank declined more than 11% due to a weaker outlook than the market had hoped to see.

With EWBC’s acquisitions and improving credit trends (net interest margin improved and delinquencies fell), it was clearly a disappointment that the company was conservative towards growth going forward.  Many investors had looked at this stock as one of the most attractive growth stories in financial services, but today’s report may make that thesis a little less secure, as management expects the balance sheet to stay about flat in the quarter.    The FDIC has given East West Bancorp some breathing room to deal with the assets of the failed banks, but we wonder if management is having a harder time integrating United Commercial Bank and Washington First International than it originally planned.

At Ockham, we have had an Overvalued rating on EWBC since just after the United Commercial Bank takeover and the stock’s resultant spike.  Thus far the market has liked the move as it has continued higher by about 17% during that time, but according to our methodology the stock is too expensive given the current fundamentals.  For example, over the past ten years EWBC has traded for between 12.2x and 27.6x times cash earnings per share, but that multiple currently stands at 30.4x well above the historically normal range.  With the latest quarter in the books and showing some serious improvements, we would have expected East West to be more aggressive towards the third quarter.  At this point it seems to us that the market has awarded EWBC a growth premium that their management is not ready to pursue just yet.  With that said after the stock’s sell-off today we may consider an upgrade to Fairly Valued, as it has fallen down into our expected price range of $12 to $16.

Read the original story at Ockham Research



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.